In the present study, we evaluated the IL-6R expression in T cells and serum sIL-6R levels in patients with MPA and GPA, which could have potential implications for the clinical application of therapeutic IL-6 inhibition in MPA and GPA patients. Here, IL6 is linked to granulomatosis with polyangiitis.